Comparison of High-Dose Methotrexate (HDM) Plus Doxorubicin to HDM Plus Etoposide-Ifosfamide in Osteosarcoma Children

Clinical trial NCT00180908 · COMPLETED

Trial details

NCT number: NCT00180908
Sponsor: Gustave Roussy, Cancer Campus, Grand Paris
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Osteosarcoma Localised High Grade Osteosarcoma of the Limbs

Start date: 1994-06-01
Enrollment: 226

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.